EXAS
Exact Sciences Corp
Company · XNAS · US · USD
Market price
$103.44
+$0.145 (+0.14%) · Today
| Date and time | Price |
|---|---|
| Aug 7, 2026, 8:00 PM | $103.29 |
| Aug 10, 2026, 5:20 PM | $103.44 |
- Period change
- +0.14%
- Period low
- $103.29
- Period high
- $103.44
- Observations
- 2
- Updated
- Aug 10, 2026, 5:20 PM
About Exact Sciences Corp
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNAS
- Operating market
- XNAS
- Country
- US
- Currency
- USD
- Market capitalization
- —
- Employees
- 7K